Interventional Oncology Devices Market - A Global and Regional Analysis

Focus on Cancer Type, Product Type, End Users, and Country-Wise Analysis - Analysis and Forecast, 2021-2030

Published Year: 2021
SKU: BHM0754SB

8100

Share With All Colleagues Globally.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Market

1.1    Global Market Outlook
         1.1.1    Product Definition
                     1.1.1.1    Embolization Devices
                     1.1.1.2    Ablation Devices
                     1.1.1.3    Supporting Devices
                     1.1.1.4    Next-Generation Devices
         1.1.2    Inclusion and Exclusion Criteria
         1.1.3    Key Findings
         1.1.4    Assumptions and Limitations
         1.1.5    Global Market Scenario
                     1.1.5.1    Realistic Growth Scenario
                     1.1.5.2    Optimistic Growth Scenario
                     1.1.5.3    Pessimistic/Conservative Growth Scenario
1.2    Industry Outlook
         1.2.1    Key Trends
                     1.2.1.1    Short-Term Impact
                     1.2.1.2    Long-Term Impact
         1.2.2    Opportunity Assessment
                     1.2.2.1    Short-Term Potential
                     1.2.2.2    Long-Term Potential
         1.2.3    Patent Analysis
                     1.2.3.1    Awaited Technological Developments
                     1.2.3.2    Patent Publication Growth Trend
                     1.2.3.3    Patent Analysis by Country/Cluster
         1.2.4    Product Benchmarking
         1.2.5    Ongoing Clinical Trial Studies
1.3    Impact of COVID-19 on the Global Interventional Oncology Devices Market
         1.3.1    Impact on Facilities
         1.3.2    Impact on Device Adoption
         1.3.3    Impact on Market Size
                     1.3.3.1    Pre-COVID-19 Phase
                     1.3.3.2    During COVID-19 Phase
                     1.3.3.3    Post-COVID-19 Phase
         1.3.4    Market Entry Barriers and Opportunities
1.4    Business Dynamics
         1.4.1    Impact Analysis
         1.4.2    Business Drivers
                     1.4.2.1    High Prevalence and Growing Incidences of Cancer
                     1.4.2.2    Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Economies
                     1.4.2.3    Expanding Role of Interventional Oncology in the Treatment of Cancer
                     1.4.2.4    Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology
         1.4.3    Business Restraints
                     1.4.3.1    Financial Burden of Product Recalls
                     1.4.3.2    Lack of Clinical Evidence for Locoregional Treatments
                     1.4.3.3    Dearth of Trained Interventional Oncologists
         1.4.4    Business Opportunities
                     1.4.4.1    High Growth Opportunity in the Emerging Economies
                     1.4.4.2    Emergence of Local Companies in Asia-Pacific and the Middle East and Africa

2 Application

2.1    Global Interventional Oncology Devices Market (by Cancer Type)
         2.1.1    Opportunity Assessment
         2.1.2    Growth Share Matrix
         2.1.3    Liver Cancer
         2.1.4    Lung Cancer
         2.1.5    Kidney Cancer
         2.1.6    Prostate Cancer
         2.1.7    Other Cancers
2.2    Global Interventional Oncology Devices Market (by End User)
         2.2.1    Opportunity Assessment
         2.2.2    Growth Share Matrix
         2.2.3    Hospitals
         2.2.4    Ambulatory Surgical Centers
         2.2.5    Others

3 Products

3.1    Global Interventional Oncology Devices Market (by Product Type)
         3.1.1    Opportunity Assessment
         3.1.2    Growth Share Matrix
         3.1.3    Ablation Devices
                     3.1.3.1    Radiofrequency Ablation
                     3.1.3.2    Microwave Ablation
                     3.1.3.3    Cryoablation
         3.1.4    Embolization Devices
                     3.1.4.1    Transcatheter Arterial Chemoembolization (TACE)
                     3.1.4.2    Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
                     3.1.4.3    Transcatheter Arterial Embolization (TAE)/Bland Embolization
         3.1.5    Supporting Devices
                     3.1.5.1    Catheters
                     3.1.5.2    Guidewires
         3.1.6    Next-Generation Devices
                     3.1.6.1    Laser Ablation
                     3.1.6.2    High Intensity Focused Ultrasound (HIFU)
                     3.1.6.3    Irreversible Electroporation Ablation (IEA)
                     3.1.6.4    Photothermal Ablation
                     3.1.6.5    Percutaneous Ethanol Ablation (PEA)
                     3.1.6.6    Theranostics

4 Region

4.1    North America Interventional Oncology Devices Market
         4.1.1    Regulatory Framework
         4.1.2    Market
                     4.1.2.1    Key Findings and Opportunity Assessment
                     4.1.2.2    Business Drivers
                     4.1.2.3    Business Restraints
                     4.1.2.4    Impact Analysis
                     4.1.2.5    Sizing and Forecast Analysis
         4.1.3    Application
                     4.1.3.1    North America Interventional Oncology Devices Market (by Cancer Type)
                     4.1.3.2    North America Interventional Oncology Devices Market (by End User)
         4.1.4    Product
                     4.1.4.1    North America Interventional Oncology Devices Market (by Product Type)
                                    4.1.4.1.1    North America Interventional Oncology Devices Market (by Ablation Devices)    
                                    4.1.4.1.2    North America Interventional Oncology Devices Market (by Embolization Devices)
         4.1.5    North America Interventional Oncology Devices Market (by Country)
                     4.1.5.1    U.S.
                                    4.1.5.1.1    Market
                                                      4.1.5.1.1.1    Business Restraints
                                                      4.1.5.1.1.2    Business Drivers
                                                      4.1.5.1.1.3    Sizing and Forecast Analysis
                                    4.1.5.1.2    Application
                                                      4.1.5.1.2.1    U.S. Interventional Oncology Devices Market (by Cancer Type)
                                                      4.1.5.1.2.2    U.S. Interventional Oncology Devices Market (by End User)
                                    4.1.5.1.3    Product
                                                      4.1.5.1.3.1    U.S. Interventional Oncology Devices Market (by Product Type)
                                                                           4.1.5.1.3.1.1    U.S. Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.1.5.1.3.1.2    U.S. Interventional Oncology Devices Market (by Embolization Devices)
                     4.1.5.2    Canada
                                    4.1.5.2.1    Market
                                                      4.1.5.2.1.1    Business Restraints
                                                      4.1.5.2.1.2    Business Drivers
                                                      4.1.5.2.1.3    Sizing and Forecast Analysis
                                    4.1.5.2.2    Application
                                                      4.1.5.2.2.1    Canada Interventional Oncology Devices Market (by Cancer Type)
                                                      4.1.5.2.2.2    Canada Oncology Devices Market (by End User)
                                    4.1.5.2.3    Product
                                                      4.1.5.2.3.1    Canada Interventional Oncology Devices Market (by Product Type)
                                                      4.1.5.2.3.1.1    Canada Interventional Oncology Devices Market (by Ablation Devices)
                                                      4.1.5.2.3.1.2    Canada Interventional Oncology Devices Market (by Embolization Devices)
4.2    Europe Interventional Oncology Devices Market
         4.2.1    Regulatory Framework
         4.2.2    Market
                     4.2.2.1    Key Findings and Opportunity Assessment
                     4.2.2.2    Business Drivers
                     4.2.2.3    Business Restraints
                     4.2.2.4    Impact Analysis
                     4.2.2.5    Sizing and Forecast Analysis
         4.2.3    Application
                     4.2.3.1    Europe Interventional Oncology Devices Market (by Cancer Type)
                     4.2.3.2    Europe Interventional Oncology Devices Market (by End User)
         4.2.4    Product
                     4.2.4.1    Europe Interventional Oncology Devices Market (by Product Type)
                                    4.2.4.1.1    Europe Interventional Oncology Devices Market (by Ablation Devices)
                                    4.2.4.1.2    Europe Interventional Oncology Devices Market (by Embolization Devices)
         4.2.5    Europe Interventional Oncology Devices Market (by Country)
                     4.2.5.1    Germany
                                    4.2.5.1.1    Market
                                                      4.2.5.1.1.1    Business Restraints
                                                      4.2.5.1.1.2    Business Drivers
                                                      4.2.5.1.1.3    Sizing and Forecast Analysis
                                    4.2.5.1.2    Application
                                                      4.2.5.1.2.1    Germany Interventional Oncology Devices Market (by Cancer Type)
                                                      4.2.5.1.2.2    Germany Interventional Oncology Devices Market (by End User)
                                    4.2.5.1.3    Product
                                                      4.2.5.1.3.1    Germany Interventional Oncology Devices Market (by Product Type)
                                                                           4.2.5.1.3.1.1    Germany Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.2.5.1.3.1.2    Germany Interventional Oncology Devices Market (by Embolization Devices)    
                     4.2.5.2    France
                                    4.2.5.2.1    Market
                                                      4.2.5.2.1.1    Business Restraints
                                                      4.2.5.2.1.2    Business Drivers
                                                      4.2.5.2.1.3    Sizing and Forecast Analysis
                                    4.2.5.2.2    Application
                                                      4.2.5.2.2.1    France Interventional Oncology Devices Market (by Cancer Type)
                                                      4.2.5.2.2.2    France Interventional Oncology Devices Market (by End User)
                                    4.2.5.2.3    Product
                                                      4.2.5.2.3.1    France Interventional Oncology Devices Market (by Product Type)
                                                                           4.2.5.2.3.1.1    France Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.2.5.2.3.1.2    France Interventional Oncology Devices Market (by Embolization Devices)
                     4.2.5.3    U.K.
                                    4.2.5.3.1    Market
                                                      4.2.5.3.1.1    Business Restraints
                                                      4.2.5.3.1.2    Business Drivers
                                                      4.2.5.3.1.3    Sizing and Forecast Analysis
                                    4.2.5.3.2    Application
                                                      4.2.5.3.2.1    U.K. Interventional Oncology Devices Market (by Cancer Type)
                                                      4.2.5.3.2.2    U.K. Interventional Oncology Devices Market (by End User)
                                    4.2.5.3.3    Product
                                                      4.2.5.3.3.1    U.K. Interventional Oncology Devices Market (by Product Type)
                                                                           4.2.5.3.3.1.1    U.K. Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.2.5.3.3.1.2    U.K. Interventional Oncology Devices Market (by Embolization Devices)
                     4.2.5.4    Italy
                                    4.2.5.4.1    Market
                                                      4.2.5.4.1.1    Business Restraints
                                                      4.2.5.4.1.2    Business Drivers
                                                      4.2.5.4.1.3    Sizing and Forecast Analysis
                                    4.2.5.4.2    Application
                                                      4.2.5.4.2.1    Italy Interventional Oncology Devices Market (by Cancer Type)
                                                      4.2.5.4.2.2    Italy Interventional Oncology Devices Market (by End User)
                                    4.2.5.4.3    Product
                                                      4.2.5.4.3.1    Italy Interventional Oncology Devices Market (by Product Type)
                                                                           4.2.5.4.3.1.1    Italy Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.2.5.4.3.1.2    Italy Interventional Oncology Devices Market (by Embolization Devices)
                     4.2.5.5    Rest-of-Europe
                                    4.2.5.5.1    Market
                                                      4.2.5.5.1.1    Business Restraints
                                                      4.2.5.5.1.2    Business Drivers
                                                      4.2.5.5.1.3    Sizing and Forecast Analysis
                                    4.2.5.5.2    Application
                                                      4.2.5.5.2.1    Rest-of-Europe Interventional Oncology Devices Market (by Cancer Type)
                                                      4.2.5.5.2.2    Rest-of-Europe Interventional Oncology Devices Market (by End User)
                                    4.2.5.5.3    Product
                                                      4.2.5.5.3.1    Rest-of-Europe Interventional Oncology Devices Market (by Product Type)
4.3    Asia-Pacific Interventional Oncology Devices Market
         4.3.1    Regulatory Framework
         4.3.2    Market
                     4.3.2.1    Key Findings and Opportunity Assessment
                     4.3.2.2    Business Drivers
                     4.3.2.3    Business Restraints
                     4.3.2.4    Impact Analysis
                     4.3.2.5    Sizing and Forecast Analysis
         4.3.3    Application
                     4.3.3.1    Asia-Pacific Interventional Oncology Devices Market (by Cancer Type)
                     4.3.3.2    Asia-Pacific Interventional Oncology Devices Market (by End User)
         4.3.4    Product
                     4.3.4.1    Asia-Pacific Interventional Oncology Devices Market (by Product Type)
                                    4.3.4.1.1    Asia-Pacific Interventional Oncology Devices Market (by Ablation Devices)
                                    4.3.4.1.2    Asia-Pacific Interventional Oncology Devices Market (by Embolization Devices)
         4.3.5    Asia-Pacific Interventional Oncology Devices Market (by Country)
                     4.3.5.1    China
                                    4.3.5.1.1    Market
                                                      4.3.5.1.1.1    Business Restraints
                                                      4.3.5.1.1.2    Business Drivers
                                                      4.3.5.1.1.3    Sizing and Forecast Analysis
                                    4.3.5.1.2    Application
                                                      4.3.5.1.2.1    China Interventional Oncology Devices Market (by Cancer Type)
                                                      4.3.5.1.2.2    China Interventional Oncology Devices Market (by End User)
                                    4.3.5.1.3    Product
                                                      4.3.5.1.3.1    China Interventional Oncology Devices Market (by Product Type)
                                                                           4.3.5.1.3.1.1    China Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.3.5.1.3.1.2    China Interventional Oncology Devices Market (by Embolization Devices)
                     4.3.5.2    Japan
                                    4.3.5.2.1    Market
                                                      4.3.5.2.1.1    Business Restraints
                                                      4.3.5.2.1.2    Business Drivers
                                                      4.3.5.2.1.3    Sizing and Forecast Analysis
                                    4.3.5.2.2    Application
                                                      4.3.5.2.2.1    Japan Interventional Oncology Devices Market (by Cancer Type)
                                                      4.3.5.2.2.2    Japan Interventional Oncology Devices Market (by End User)
                                    4.3.5.2.3    Product
                                                      4.3.5.2.3.1    Japan Interventional Oncology Devices Market (by Product Type)
                                                                           4.3.5.2.3.1.1    Japan Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.3.5.2.3.1.2    Japan Interventional Oncology Devices Market (by Embolization Devices)
                     4.3.5.3    India
                                    4.3.5.3.1    Market
                                                      4.3.5.3.1.1    Business Restraints
                                                      4.3.5.3.1.2    Business Drivers
                                                      4.3.5.3.1.3    Sizing and Forecast Analysis
                                    4.3.5.3.2    Application
                                                      4.3.5.3.2.1    India Interventional Oncology Devices Market (by Cancer Type)
                                                      4.3.5.3.2.2    India Interventional Oncology Devices Market (by End User)
                                    4.3.5.3.3    Product
                                                      4.3.5.3.3.1    India Interventional Oncology Devices Market (by Product Type)
                                                                           4.3.5.3.3.1.1    India Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.3.5.3.3.1.2    India Interventional Oncology Devices Market (by Embolization Devices)
                      4.3.5.4    Australia
                                    4.3.5.4.1    Market
                                                      4.3.5.4.1.1    Business Restraints
                                                      4.3.5.4.1.2    Business Drivers
                                                      4.3.5.4.1.3    Sizing and Forecast Analysis
                                    4.3.5.4.2    Application
                                                      4.3.5.4.2.1    Australia Interventional Oncology Devices Market (by Cancer Type)
                                                      4.3.5.4.2.2    Australia Interventional Oncology Devices Market (by End User)
                                    4.3.5.4.3    Product
                                                      4.3.5.4.3.1    Australia Interventional Oncology Devices Market (by Product Type)
                                                                           4.3.5.4.3.1.1    Australia Interventional Oncology Devices Market (by Ablation Devices)
                                                                           4.3.5.4.3.1.2    Australia Interventional Oncology Devices Market (by Embolization Devices)
                     4.3.5.5    Rest-of-Asia-Pacific
                                    4.3.5.5.1    Market
                                                      4.3.5.5.1.1    Business Restraints
                                                      4.3.5.5.1.2    Business Drivers
                                                      4.3.5.5.1.3    Sizing and Forecast Analysis
                                    4.3.5.5.2    Application
                                                      4.3.5.5.2.1    Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Cancer Type)
                                                      4.3.5.5.2.2    Rest-of-Asia-Pacific Interventional Oncology Devices Market (by End User)
                                    4.3.5.5.3    Product
                                                      4.3.5.5.3.1    Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Product Type)
4.4    Rest-of-the-World Interventional Oncology Devices Market
         4.4.1    Regulatory Framework
         4.4.2    Market
                     4.4.2.1    Key Findings and Opportunity Assessment
                     4.4.2.2    Business Drivers
                     4.4.2.3    Business Restraints
                     4.4.2.4    Impact Analysis
                     4.4.2.5    Sizing and Forecast Analysis
         4.4.3    Application
                     4.4.3.1    Rest-of-the-World Interventional Oncology Devices Market (by Cancer Type)
                     4.4.3.2    Rest-of-the-World Interventional Oncology Devices Market (by End User)
         4.4.4    Product
                     4.4.4.1    Rest-of-the-World Interventional Oncology Devices Market (by Product Type)
                                    4.4.4.1.1    Rest-of-the-World Interventional Oncology Devices Market (by Ablation Devices)
                                    4.4.4.1.2    Rest-of-the-World Interventional Oncology Devices Market (by Embolization Devices)
         4.4.5    Rest-of-the-World Interventional Oncology Devices Market (by Region)
                     4.4.5.1    Latin America
                                    4.4.5.1.1    Market
                                                      4.4.5.1.1.1    Business Restraints
                                                      4.4.5.1.1.2    Business Drivers
                                                      4.4.5.1.1.3    Sizing and Forecast Analysis
                                    4.4.5.1.2    Application
                                                      4.4.5.1.2.1    Latin America Interventional Oncology Devices Market (by Cancer Type)    
                                                      4.4.5.1.2.2    Latin America Interventional Oncology Devices Market (by End User)
                                    4.4.5.1.3    Product
                                                      4.4.5.1.3.1    Latin America Interventional Oncology Devices Market (by Product Type)    
                     4.4.5.2    Middle East and Africa
                                    4.4.5.2.1    Market
                                                      4.4.5.2.1.1    Business Restraints
                                                      4.4.5.2.1.2    Business Drivers
                                                      4.4.5.2.1.3    Sizing and Forecast Analysis
                                    4.4.5.2.2    Application
                                                      4.4.5.2.2.1    Middle East and Africa Interventional Oncology Devices Market (by Cancer Type)
                                                      4.4.5.2.2.2    Middle East and Africa Oncology Devices Market (by End User)
                                    4.4.5.2.3    Product
                                                      4.4.5.2.3.1    Middle East and Africa Interventional Oncology Devices Market (by Product Type)

5 Markets - Competitive Benchmarking & Company Profiles

5.1    Competitive Benchmarking and Company Profiles
         5.1.1    Competitive Landscape
                     5.1.1.1    Key Strategies and Developments
                                    5.1.1.1.1    Mergers and Acquisitions
                                    5.1.1.1.2    Regulatory and Legal Activities
                                    5.1.1.1.3    New Offerings
                                    5.1.1.1.4    Partnerships, Alliances, and Business Expansion
                                    5.1.1.1.5    Funding Activities
5.2    Market Share Analysis
5.3    Company Profiles
         5.3.1    AngioDynamics, Inc.
                     5.3.1.1    Company Overview
                     5.3.1.2    Role of AngioDynamics, Inc. in the Global Interventional Oncology Devices Market
                     5.3.1.3    Financials
                     5.3.1.4    Recent Developments
                     5.3.1.5    SWOT Analysis
         5.3.2    Becton, Dickinson and Company
                     5.3.2.1    Company Overview
                     5.3.2.2    Role of Becton, Dickinson, and Company in the Global Interventional Oncology Devices Market
                     5.3.2.3    Financials
                     5.3.2.4    Recent Developments
                     5.3.2.5    SWOT Analysis
         5.3.3    Boston Scientific Corporation
                     5.3.3.1    Company Overview
                     5.3.3.2    Role of Boston Scientific Corporation in the Global Interventional Oncology Devices Market
                     5.3.3.3    Financials
                     5.3.3.4    Recent Developments
                     5.3.3.5    SWOT Analysis
         5.3.4    Eckert & Ziegler BEBIG AG
                     5.3.4.1    Company Overview
                     5.3.4.2    Role of Eckert & Ziegler BEBIG AG in the Global Interventional Oncology Devices Market
                     5.3.4.3    Financials
                     5.3.4.4    Recent Developments
                     5.3.4.5    SWOT Analysis
         5.3.5    HealthTronics, Inc.
                     5.3.5.1    Company Overview
                     5.3.5.2    Role of HealthTronics, Inc. in the Global Interventional Oncology Devices Market
                     5.3.5.3    SWOT Analysis
         5.3.6    IceCure Medical Ltd
                     5.3.6.1    Company Overview
                     5.3.6.2    Role of IceCure Medical Ltd in the Global Interventional Oncology Devices Market
                     5.3.6.3    Recent Developments
                     5.3.6.4    SWOT Analysis
        5.3.7    Johnson & Johnson
                     5.3.7.1    Company Overview
                     5.3.7.2    Role of Johnson & Johnson in the Global Interventional Oncology Devices Market
                     5.3.7.3    Financials
                     5.3.7.4    Recent Developments
                     5.3.7.5    SWOT Analysis
         5.3.8    Medtronic plc
                     5.3.8.1    Company Overview
                     5.3.8.2    Role of Medtronic plc in the Global Interventional Oncology Devices Market    
                     5.3.8.3    Financials
                     5.3.8.4    Recent Developments
                     5.3.8.5    SWOT Analysis
         5.3.9    MedWaves, Inc.
                     5.3.9.1    Company Overview
                     5.3.9.2    Role of MedWaves, Inc. in the Global Interventional Oncology Devices Market
                     5.3.9.3    SWOT Analysis
       5.3.10    Merit Medical Systems, Inc.
                     5.3.10.1    Company Overview
                     5.3.10.2    Role of Merit Medical Systems, Inc. in the Global Interventional Oncology Devices Market
                     5.3.10.3    Financials
                     5.3.10.4    Recent Developments
                     5.3.10.5    SWOT Analysis
       5.3.11    Sanarus Technologies, Inc.
                     5.3.11.1    Company Overview
                     5.3.11.2    Role of Sanarus Technologies, Inc. in the Global Interventional Oncology Devices Market
                     5.3.11.3    SWOT Analysis
       5.3.12    Sonablate Corp
                     5.3.12.1    Company Overview
                     5.3.12.2    Role of Sonablate Corp in the Global Interventional Oncology Devices Market
                     5.3.12.3    Recent Developments
                     5.3.12.4    SWOT Analysis
       5.3.13    Terumo Corporation
                     5.3.13.1    Company Overview
                     5.3.13.2    Role of Terumo Corporation in the Global Interventional Oncology Devices Market
                     5.3.13.3    Financials
                     5.3.13.4    Recent Developments
                     5.3.13.5    SWOT Analysis
       5.3.14    Trod Medical
                     5.3.14.1    Company Overview
                     5.3.14.2    Role of Trod Medical in the Global Interventional Oncology Devices Market    
                     5.3.14.3    Recent Developments
                     5.3.14.4    SWOT Analysis
       5.3.15    Varian Medical Systems, Inc.
                     5.3.15.1    Company Overview
                     5.3.15.2    Role of Varian Medical Systems, Inc. in the Global Interventional Oncology Devices Market
                     5.3.15.3    Financials
                     5.3.15.4    Recent Developments
                     5.3.15.5    SWOT Analysis

6 Research Methodology

6.1    Data Collection and Analysis
6.2    Data Sources
         6.2.1    Primary Sources
         6.2.2    Secondary Sources
6.3    Data Triangulation
6.4    Market Estimation
6.5    Assumptions and Limitation

List of Tables

Table 1:    Global Interventional Oncology Devices Market, Key Trends
Table 2:    Global Interventional Oncology Devices Market, Awaited Technology Developments
Table 3:    Global Interventional Oncology Devices Market, Product Benchmarking
Table 4:    Global Interventional Oncology Devices Market, Ongoing Clinical Trial Studies
Table 5:    Global Age Standardized Cancer Rates (Per 100,000 People) (by Country), 2018
Table 6:    Reimbursement Scenario for Hepatic Embolization in the U.S., 2018
Table 7:    Reimbursement Scenario for Renal Embolization in the U.S., 2018
Table 8:    North America Interventional Oncology Devices Market Regulatory Framework
Table 9:    North America Interventional Oncology Devices Market Dynamics Impact Analysis
Table 10:    Canadian Cancer Statistics Snapshot of Incidence, Mortality and Survival Estimates (by Cancer Type), 2019
Table 11:    Challenges in MDR Implementation
Table 12:    Europe Interventional Oncology Devices Market Dynamics Impact Analysis
Table 13:    Asia-Pacific Interventional Oncology Devices Market Regulatory Framework
Table 14:    Asia-Pacific Interventional Oncology Devices Market Dynamics Impact Analysis
Table 15:    Rest-of-the-World Interventional Oncology Devices Market Regulatory Framework
Table 16:    Rest-of-the-World Interventional Oncology Devices Market Dynamics Impact Analysis

List of Figures

Figure 1:    Number of People with Cancer (by Age) in Global Population, 1975-2020
Figure 2:    Global Interventional Oncology Devices Market, $Million, 2020-2030
Figure 3:    Global Interventional Oncology Devices Market, Impact Analysis
Figure 4:    Global Interventional Oncology Devices Market, Industry Analysis
Figure 5:    Global Interventional Oncology Devices Market, Competitive Benchmarking
Figure 6:    Global Interventional Oncology Devices Market (by Product Type), 2020 Vs. 2030
Figure 7:    Global Interventional Oncology Devices Market (by Cancer Type), 2020 Vs. 2030
Figure 8:    Global Interventional Oncology Devices Market (by Region), 2020 and 2030
Figure 9:    Global Interventional Oncology Devices Market Segmentation
Figure 10:    Global Interventional Oncology Devices Market, Realistic Growth Scenario, $Million, 2020-2030
Figure 11:    Global Interventional Oncology Devices Market, Optimistic Growth Scenario, $Million, 2020-2030
Figure 12:    Global Interventional Oncology Devices Market, Pessimistic Growth Scenario, $Million, 2020-2030
Figure 13:    Global Interventional Oncology Devices Market, Short-Term Potential, $Million, 2020-2025
Figure 14:    Global Interventional Oncology Devices Market, Long-Term Growth, $Million, 2025-2030
Figure 15:    Global Interventional Oncology Devices Market, Patent Publication Growth Trend, January 2015-September 2021
Figure 16:    Global Interventional Oncology Devices Market, Patent Filing Trend (by Country/Cluster)
Figure 17:    Global Interventional Oncology Devices Market, Impact Analysis
Figure 18:    Global Interventional Oncology Devices Market (by Cancer Type)
Figure 19:    Global Interventional Oncology Devices Market Incremental Opportunity (by Cancer Type), $Million, 2020-2030
Figure 20:    Global Interventional Oncology Devices Market, Growth Share Matrix (by Cancer Type),2020-2030
Figure 21:    Global Interventional Oncology Devices Market (by Liver Cancer), $Million, 2020-2030
Figure 22:    Global Interventional Oncology Devices Market (by Lung Cancer), $Million, 2020-2030
Figure 23:    Global Interventional Oncology Devices Market (by Kidney Cancer), $Million, 2020-2030
Figure 24:    Global Interventional Oncology Devices Market (by Prostate Cancer), $Million, 2020-2030
Figure 25:    Global Interventional Oncology Devices Market (by Other Cancers), $Million, 2020-2030
Figure 26:    Global Interventional Oncology Devices Market (by End User)
Figure 27:    Global Interventional Oncology Devices Market Incremental Opportunity (by End User), $Million, 2020-2030
Figure 28:    Global Interventional Oncology Devices Market, Growth Share Matrix (by End User), 2020-2030
Figure 29:    Global Interventional Oncology Devices Market (by Hospitals), $Million, 2020-2030
Figure 30:    Global Interventional Oncology Devices Market (by Ambulatory Surgical Centers), $Million, 2020-2030
Figure 31:    Global Interventional Oncology Devices Market (by Others), $Million, 2020-2030
Figure 32:    Global Interventional Oncology Devices Market (by Product Type)
Figure 33:    Global Interventional Oncology Devices Market Incremental Opportunity (by Product Type), $Million, 2020-2030
Figure 34:    Global Interventional Oncology Devices Market, Growth Share Matrix (by Product Type), 2020-2030
Figure 35:    Global Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 36:    Global Ablation Devices Market (by Radiofrequency Ablation), $Million, 2020-2030
Figure 37:    Global Ablation Devices Market (by Microwave Ablation), $Million, 2020-2030
Figure 38:    Global Ablation Devices Market (by Cryoablation), $Million, 2020-2030
Figure 39:    Global Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 40:    Global Embolization Devices Market (by Transcatheter Arterial Chemoembolization), $Million, 2020-2030
Figure 41:    Global Embolization Devices Market (by Transcatheter Arterial Radioembolization), $Million, 2020-2030
Figure 42:    Global Embolization Devices Market (by Transcatheter Arterial Embolization), $Million, 2020-2030
Figure 43:    Global Interventional Oncology Devices Market (by Supporting Devices), $Million, 2020-2030
Figure 44:    Global Supporting Devices Market (by Catheters), $Million, 2020-2030
Figure 45:    Global Supporting Devices Market (by Guidewires), $Million, 2020-2030
Figure 46:    Global Interventional Oncology Devices Market (by Next-Generation Devices), $Million, 2020-2030
Figure 47:    Global Next-Generation Devices Market (by Laser Ablation), $Million, 2020-2030
Figure 48:    Global Next-Generation Devices Market (by High Intensity Focused Ultrasound), $Million, 2020-2030
Figure 49:    Global Next-Generation Devices Market (by Irreversible Electroporation Ablation), $Million, 2020-2030
Figure 50:    Global Next-Generation Devices Market (by Photothermal Ablation), $Million, 2020-2030
Figure 51:    Global Next-Generation Devices Market (by Percutaneous Ethanol Ablation), $Million, 2020-2030
Figure 52:    Global Next-Generation Devices Market (by Theranostics), $Million, 2020-2030
Figure 53:    Global Interventional Oncology Devices Market (by Region), 2020 and 2030
Figure 54:    North America Interventional Oncology Devices Market Incremental Growth Opportunity (by Country), $Million, 2020-2030
Figure 55:    North America Interventional Oncology Devices Market, $Million, 2020-2030
Figure 56:    North America Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 57:    North America Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 58:    North America Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 59:    North America Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 60:    North America Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 61:    U.S. Interventional Oncology Devices Market, $Million, 2020-2030
Figure 62:    U.S. Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 63:    U.S. Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 64:    U.S. Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 65:    U.S. Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 66:    U.S. Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 67:    Canada Interventional Oncology Devices Market, $Million, 2020-2030
Figure 68:    Canada Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 69:    Canada Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 70:    Canada Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 71:    Canada Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 72:    Canada Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 73:    Europe Interventional Oncology Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 74:    Europe Interventional Oncology Devices Market, $Millon, 2020-2030
Figure 75:    Europe Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 76:    Europe Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 77:    Europe Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 78:    Europe Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 79:    Europe Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 80:    Germany Interventional Oncology Devices Market, $Million, 2020-2030
Figure 81:    Germany Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 82:    Germany Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 83:    Germany Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 84:    Germany Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 85:    Germany Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 86:    France Interventional Oncology Devices Market, $Million, 2020-2030
Figure 87:    France Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 88:    France Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 89:    France Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 90:    France Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 91:    France Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 92:    U.K. Interventional Oncology Devices Market, $Million, 2020-2030
Figure 93:    U.K. Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 94:    U.K. Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 95:    U.K. Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 96:    U.K. Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 97:    U.K. Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 98:    Italy Interventional Oncology Devices Market, $Million, 2020-2030
Figure 99:    Italy Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 100:    Italy Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 101:    Italy Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 102:    Italy Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 103:    Italy Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 104:    Rest-of-Europe Interventional Oncology Devices Market, $Million, 2020-2030
Figure 105:    Rest-of-Europe Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 106:    Rest-of-Europe Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 107:    Rest-of-Europe Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 108:    Asia-Pacific Interventional Oncology Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 109:    Asia-Pacific Interventional Oncology Devices Market, $Million, 2020-2030
Figure 110:    Asia-Pacific Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 111:    Asia-Pacific Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 112:    Asia-Pacific Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 113:    Asia-Pacific Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 114:    Asia-Pacific Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 115:    China Interventional Oncology Devices Market, $Million, 2020-2030
Figure 116:    China Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 117:    China Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 118:    China Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 119:    China Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 120:    China Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 121:    Japan Interventional Oncology Devices Market, $Million, 2020-2030
Figure 122:    Japan Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 123:    Japan Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 124:    Japan Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 125:    Japan Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 126:    Japan Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 127:    India Interventional Oncology Devices Market, $Million, 2020-2030
Figure 128:    India Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 129:    India Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 130:    India Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 131:    India Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 132:    India Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 133:    Australia Interventional Oncology Devices Market, $Million, 2020-2030
Figure 134:    Australia Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 135:    Australia Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 136:    Australia Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 137:    Australia Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 138:    Australia Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 139:    Rest-of-Asia-Pacific Interventional Oncology Devices Market, $Million, 2020-2030
Figure 140:    Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 141:    Rest-of-Asia-Pacific Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 142:    Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 143:    Rest-of-the-World Interventional Oncology Devices Market Incremental Growth Opportunity, $Million, 2020 -2030
Figure 144:    Rest-of-the-World Interventional Oncology Devices Market, $Million, 2020-2030
Figure 145:    Rest-of-The-World Interventional Oncology Devices Market (by Cancer Type),$Million, 2020-2030
Figure 146:    Rest-of-the-World Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 147:    Rest-of-the-World Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 148:    Rest-of-the-World Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 149:    Rest-of-the-World Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 150:    Latin America Interventional Oncology Devices Market, $Million, 2020-2030
Figure 151:    Latin America Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 152:    Latin America Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 153:    Latin America Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 154:    Middle East and Africa Interventional Oncology Devices Market, $Million, 2020-2030
Figure 155:    Middle East and Africa Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 156:    Middle East and Africa Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 157:    Middle East and Africa Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 158:    Share of Key Developments and Strategies, January 2015-September 2021
Figure 159:    Mergers and Acquisitions Share (by Company), January 2015-September 2021
Figure 160:    Regulatory and Legal Activities Share (by Company), January 2015-September 2021
Figure 161:    New Offerings Share (by Company), January 2015-September 2021
Figure 162:    Partnerships, Alliances, and Business Expansion Share (by Company), January 2015-September 2021
Figure 163:    Funding Activities Share (by Company), January 2015-September 2021
Figure 164:    Market Share Analysis (by Company) for the Global Interventional Oncology Devices Market, 2020
Figure 165:    AngioDynamics, Inc.: Overall Product Portfolio
Figure 166:    AngioDynamics, Inc.: Overall Financials, $Million, 2018-2020
Figure 167:    AngioDynamics,Inc.: Revenue (by Product Segment), $Million, 2018-2020
Figure 168:    AngioDynamics, Inc.: Revenue (by Region), $Million,2018-2020
Figure 169:    AngioDynamics, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 170:    Becton, Dickinson and Company: Overall Product Portfolio
Figure 171:    Becton, Dickinson and Company: Overall Financials, $Million, 2018-2020
Figure 172:    Becton, Dickinson and Company: Revenue (by Product Segment), $Million, 2018-2020
Figure 173:    Becton, Dickinson and Company: Revenue (by Region), $Million, 2018-2020
Figure 174:    Becton, Dickinson, and Company: R&D Expenditure, $Million, 2018-2020
Figure 175:    Boston Scientific Corporation: Overall Product Portfolio
Figure 176:    Boston Scientific Corporation: Overall Financials, $Million, 2018-2020
Figure 177:    Boston Scientific Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 178:    Boston Scientific Corporation: Revenue (by Region),$Million, 2018-2020
Figure 179:    Boston Scientific Corporation: R&D Expenditure, $Million, 2018-2020
Figure 180:    Eckert & Ziegler BEBIG AG: Overall Product Portfolio
Figure 181:    Eckert & Ziegler BEBIG AG: Overall Financials, $Million, 2018-2020
Figure 182:    Eckert & Ziegler BEBIG AG: Revenue (by Product Segment),$Million, 2018
Figure 183:    Eckert & Ziegler BEBIG AG: Revenue (by Product Segment),$Million, 2019-2020
Figure 184:    Eckert & Ziegler BEBIG AG: Revenue (by Region),$Million, 2018-2020
Figure 185:    Eckert & Ziegler BEBIG AG: R&D Expenditure, $Million, 2018-2020
Figure 186:    HealthTronics, Inc.: Overall Product Portfolio
Figure 187:    IceCure Medical Ltd.: Overall Product Portfolio
Figure 188:    Johnson & Johnson: Overall Product Portfolio
Figure 189:    Johnson & Johnson: Overall Financials, $Million, 2018-2020
Figure 190:    Johnson & Johnson: Revenue (by Product Segment), $Million, 2018-2020
Figure 191:    Johnson & Johnson: Revenue (by Region), $Million, 2018-2020
Figure 192:    Johnson & Johnson: R&D Expenditure, $Million, 2018-2020
Figure 193:    Medtronic plc: Overall Product Portfolio
Figure 194:    Medtronic plc: Overall Financials, $Million, 2018-2020
Figure 195:    Medtronic plc: Revenue (by Segment), $Million, 2018-2020
Figure 196:    Medtronic plc: Revenue (by Region), $Million,2018-2020
Figure 197:    Medtronic plc: R&D Expenditure, $Million, 2018-2020
Figure 198:    MedWaves, Inc.: Overall Product Portfolio
Figure 199:    Merit Medical Systems, Inc.: Overall Product Portfolio
Figure 200:    Merit Medical Systems, Inc.: Overall Financials, $Million,2018-2020
Figure 201:    Merit Medical Systems, Inc.: Revenue (by Product Segment), $Million, 2018-2020
Figure 202:    Merit Medical Systems, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 203:    Merit Medical Systems, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 204:    Sanarus Technologies, Inc.: Overall Product Portfolio
Figure 205:    Sonablate Corp: Overall Product Portfolio
Figure 206:    Terumo Corporation: Overall Product Portfolio
Figure 207:    Terumo Corporation: Overall Financials, $Million, 2018-2020
Figure 208:    Terumo Corporation: Revenue (by Segment),$Million, 2018-2020
Figure 209:    Terumo Corporation: Revenue (by Region), $Million, 2018-2020
Figure 210:    Terumo Corporation: R&D Expenditure, $Million, 2018-2020
Figure 211:    Trod Medical: Overall Product Portfolio
Figure 212:    Varian Medical Systems, Inc.: Overall Product Portfolio
Figure 213:    Varian Medical Systems, Inc.: Overall Financials, $Million, 2017-2019
Figure 214:    Varian Medical Systems, Inc.: Revenue (by Business Segment), $Million, 2017-2019
Figure 215:    Varian Medical Systems, Inc.: Revenue (by Region), $Million,2017-2019
Figure 216:    Varian Medical Systems, Inc.: R&D Expenditure, $Million, 2017-2019
Figure 217:    Interventional Oncology Devices Market Research Methodology
Figure 218:    Primary Research
Figure 219:    Secondary Research
Figure 220:    Data Triangulation
Figure 221:    Bottom-Up Approach
Figure 222:    Assumptions and Limitations

 
 

Market Report Coverage

Interventional Oncology Devices Market

Base Year

2020

Market Size in 2020

$2,429.2 Million

Forecast Period

2021-2030

Value Projection and Estimation by 2030

$7,861.1 Million

CAGR During Forecast Period

12.35%

Number of Tables

16

Number of Pages

261

Number of Figures

222

Market Segmentation

•    Cancer Type – Liver Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, and Other Cancers

•    End User – Hospitals, Ambulatory Surgical Centers, and Others

•    Product Type – Ablation Devices (Radiofrequency Ablation, Microwave Ablation, and Cryoablation), Embolization Devices (Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization (TAE)/Bland Embolization), Supporting Devices (Catheters and Guidewires), and Next-Generation Devices (Irreversible Electroporation Ablation, Percutaneous Ethanol Ablation, High Intensity Focused Ultrasound, Laser Ablation, Photothermal Ablation, and Theranostics)

Regional Segmentation

•    North America - U.S. and Canada

•    Europe - Germany, U.K., France, Italy, and Rest-of-Europe

•    Asia-Pacific - Japan, China, India, Australia, and Rest-of-Asia-Pacific

•    Rest-of-the-World - Latin America and Middle East and Africa

Market Growth Drivers

•    High Prevalence and Growing Incidences of Cancer

•    Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Economies

•    Expanding Role of Interventional Oncology in the Treatment of Cancer

•    Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology

Market Challenges

•    Financial Burden of Product Recalls

•    Lack of Clinical Evidence for Locoregional Treatments

•    Dearth of Trained Interventional Oncologists

Market Opportunities

•    High Growth Opportunity in the Emerging Economies

•    Emergence of Local Companies in Asia-Pacific and the Middle East and Africa

Key Companies Profiled

AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, Varian Medical Systems, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of interventional oncology devices market, they will be able to do the following:

•    Understand their position compared to some of the key players in the market
•    Stay updated with novel technology integration, features, and the latest developments in the market
•    Understand the impact of COVID-19 on the adoption of interventional oncology devices and the entry barriers because of it
•    Gain insights into end-user perception with respect to the adoption of interventional oncology
•    Identify some of the key players in the market and understand their valuable contribution

Key Questions Answered in the Global Interventional Oncology Devices Market Report

•    What are the key trends that have a strong influence on the global interventional oncology devices market? How did the COVID-19 pandemic impact the growth of the interventional oncology devices market?
•    What are the key development strategies which are implemented by the key players to maintain and capture market share? 
•    How does the patent landscape of interventional oncology devices look like?
•    What are the major market drivers, challenges, and opportunities in the global interventional oncology devices market?
•    Which leading companies are dominating the global interventional oncology devices market?
•    What are the regulations about the global interventional oncology devices market? What are the initiatives implemented by different government bodies to reduce the cancer rate?
•    What was the market value of the leading segments and sub-segments of the global interventional oncology devices market? 
•    How is each segment of the global interventional oncology devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?
•    Which region carries the potential for the significant expansion of key companies for the interventional oncology devices market?

Report Summary

Global Interventional Oncology Devices Market Industry Overview

Interventional oncology procedures are suitable for those cancer patients who do not respond to chemotherapy and are not fit for surgery. Interventional oncology procedures require devices such as embolization and ablation devices, as well as an array of support devices such as catheters.

The global interventional oncology devices market is an emerging market in the medical device ecosystem. The market comprises various key medical device companies and several start-ups developing advanced solutions for cancer treatment. Furthermore, the market also has unique products in the pipeline that would further improve the technology integration in cancer treatment. The major factors that have a positive impact on the market’s growth include high prevalence and growing incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in treatment of cancer, and availability of private and government funding for grants for research in the field of interventional oncology.

During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted.

The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030. The market is expected to grow at a CAGR of 12.35% during the forecast period from 2021 to 2030.

Global Interventional Oncology Devices Market Drivers

The factors driving the growth of the market include the high prevalence and growing Incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in the treatment of cancer, availability of private and government funding and grants for research in the field of interventional oncology. The field of interventional oncology is constantly evolving with the introduction of novel technologies. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.

Thus, as the prevalence of cancer continues to increase, especially in emerged economies, technology adoption will continue to grow. This will consequently advance the growth of interventional oncology and, subsequently, the global market.

Global Interventional Oncology Devices Market Challenges

The factors restraining the growth of the global interventional oncology devices market include the financial burden of product recalls, the lack of clinical evidence for locoregional treatments, and the dearth of trained interventional oncologists. Shortage of clinical data and increasing incidences of serious side effects associated with the use of interventional oncology devices have led to numerous instances of interventional oncology device product recalls that are critically hindering the growth of the interventional oncology devices market.

Another major restraint for the global interventional oncology devices market is the shortage of skilled interventional oncology professionals in most countries who can perform interventional oncology procedures. The situation continues to worsen, as cancer is rising faster than the rate at which new interventional oncologists are entering the field.

Global Interventional Oncology Devices Market Opportunities

High growth opportunities in the emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global interventional oncology devices market growth.

There is massive scope for interventional oncology devices in developing countries. Countries such as China, India, Australia, and South Korea possess populations with high prevalence and incidence rates of cancer, which drives the adoption of interventional oncology devices for the treatment of cancer, which would surge the overall interventional oncology devices market in these emerging countries.

Impact of COVID-19 on the Global Interventional Oncology Devices Market

During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.

Market Segmentation

Global Interventional Oncology Devices Market (by Cancer Type)

The global interventional oncology devices market, on the basis of cancer type, has been segmented into liver cancer, lung cancer, kidney cancer, prostate cancer, and other cancer.

The liver cancer segment accounted for the highest share of the market, which can be attributed to high consumption of alcohol, chronic viral hepatitis, liver cirrhosis, and rise in the obesity index globally. Moreover, liver cancer is less common in the U.S. than in sub-Saharan Africa and South Asian countries. Liver cancer accounts for more than 70,000 deaths each year.

Global Interventional Oncology Devices Market (by Product Type)

The global interventional oncology devices market, on the basis of product type, has been segmented into ablation devices, embolization devices, supporting devices, and next-generation devices.

Ablation is used as the first line of treatment in a few cases of hepatocellular carcinoma, and it is also considered an important option for patients who are either not eligible for surgery or have failed chemotherapy.  Furthermore, advancements in interventional oncology would propel the growth of next-generation devices in the forecast period 2021-2030.

Global Interventional Oncology Devices Market (by End User)

The global interventional oncology devices market, on the basis of end users, has been segmented into three categories, namely, hospitals, ambulatory surgical centers (ASCs), and others.

Hospitals are at the forefront in terms of interventional oncology devices adoption. The increasing focus on evidence-based care has been one of the strongest drivers for the adoption of interventional oncology.

The growing prominence for outpatient surgeries and rising establishments of ASCs are the leading factors promoting the market's growth for the global interventional oncology devices. The adoption of interventional oncology devices in ambulatory surgical centers can be boosted by prioritizing the increasing demand for minimally invasive surgeries. 

Global Interventional Oncology Devices Market (by Region)

The different regions covered under the global interventional oncology devices market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominates the global interventional oncology devices market due to high prevalence of cancer, growing geriatric population, and high reimbursement rates. The Asia-Pacific interventional oncology devices market is one of the lucrative markets with immense potential for expansion by key players of the global interventional oncology market. The Asia-Pacific interventional oncology devices market is expected to grow at the fastest rate in the forecast period, and this can be attributed to the massive geriatric population base, driving the demand for minimally invasive and non-invasive surgical procedures

Key Market Players and Competition Synopsis

Some of the key players operating in the market include AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, and Varian Medical Systems, Inc.

Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been mergers and acquisitions followed by regulatory and legal activities.

FAQ's

What is the estimated growth rate of global interventional oncology devices market in the coming years?

The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030. The market is expected to grow at a CAGR of 12.35% during the forecast period from 2021 to 2030.

Which are the top market players operating in the global interventional oncology devices market?

The top market players are AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, Varian Medical Systems, Inc.

What are factors driving the growth of global interventional oncology devices market?

Factors driving the growth of the global interventional oncology devices market are high prevalence and growing incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in the treatment of cancer, and availability of private and government funding and grants for research in the field of interventional oncology.

What are challenges restricting the growth of the global interventional oncology devices market?

Some of the main challenges restricting the growth of the global interventional oncology devices market are financial burden of product recalls, lack of clinical evidence for locoregional treatments, and dearth of trained interventional oncologists.

What are some of the opportunities in the global interventional oncology devices market?

The potential opportunities that are likely to boost the growth of the global interventional oncology devices market are high growth opportunity in the emerging economies, and emergence of local companies in Asia-Pacific and the Middle East and Africa.

You may also like

Published Year: 2021

Global Radiation Dose Management Market: Analysis and Forecast, 2021-2030

The radiation dose management market is expected to grow at a CAGR of 10.96% during the...

 
Published Year: 2021

Global Radiofrequency-Based Devices Market: Analysis and Forecast, 2021-2030

The global market for radiofrequency-based devices is predicted to grow at a CAGR of 12.81%...

 
Published Year: 2019

Global Radiation Therapy Quality Assurance (QA) Phantoms Market: Focus on Technology, Therapies, Reg

Radiation Therapy Quality Assurance Phantoms Industry Analysis by BIS Research projects the...

 

Interventional Oncology Devices Market - A Global and Regional Analysis

Focus on Cancer Type, Product Type, End Users, and Country-Wise Analysis - Analysis and Forecast, 2021-2030